Author:
Ye Sheng-Long,Yang Jiamei,Bie Ping,Zhang Shuijun,Chen Xiaoping,Liu Fengyong,Liu Luming,Zhou Jie,Dou Kefeng,Hao Chunyi,Shao Guoliang,Xia Qiang,Chen Yajin,Yang Jijin,Deng Xiaxing,Liu Yunpeng,Yuan Yunfei,Fu Zhiren,Nakajima Keiko,Lv Zhengguang
Funder
Bayer HealthCare Pharmaceutical Company, Ltd., China.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference32 articles.
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.
2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
3. Makuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence-based guidelines from Japan. World J Gastroenterol. 2006;12:828–9.
4. Qin S, Primary Liver Cancer Diagnosis and Treatment Expert Panel of the Chinese Ministry of Health. Guidelines on the diagnosis and treatment of primary liver cancer (2011 edition). Chin Clin Oncol. 2012;1:10.
5. Hung H. Treatment modalities for hepatocellular carcinoma. Curr Cancer Drug Targets. 2005;5:131–8.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献